GIORGI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 9.886
AS - Asia 5.993
EU - Europa 4.591
SA - Sud America 566
AF - Africa 219
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 21.275
Nazione #
US - Stati Uniti d'America 9.550
CN - Cina 1.795
SG - Singapore 1.584
IT - Italia 1.511
VN - Vietnam 793
SE - Svezia 732
HK - Hong Kong 701
DE - Germania 582
BR - Brasile 500
BG - Bulgaria 338
KR - Corea 321
GB - Regno Unito 304
CA - Canada 269
TR - Turchia 267
FR - Francia 212
UA - Ucraina 201
FI - Finlandia 185
RU - Federazione Russa 162
IN - India 148
CH - Svizzera 134
JP - Giappone 103
CI - Costa d'Avorio 78
BD - Bangladesh 59
GR - Grecia 56
AT - Austria 43
NG - Nigeria 38
IQ - Iraq 36
BE - Belgio 32
MX - Messico 32
IR - Iran 23
PK - Pakistan 23
ZA - Sudafrica 23
SN - Senegal 22
PL - Polonia 21
SA - Arabia Saudita 21
NL - Olanda 20
AR - Argentina 19
ID - Indonesia 19
MA - Marocco 14
UZ - Uzbekistan 13
VE - Venezuela 13
ES - Italia 12
EC - Ecuador 11
EU - Europa 9
AU - Australia 8
KZ - Kazakistan 8
NP - Nepal 8
CR - Costa Rica 7
EG - Egitto 7
IE - Irlanda 7
KE - Kenya 7
OM - Oman 7
PH - Filippine 7
JO - Giordania 6
KG - Kirghizistan 6
LT - Lituania 6
MY - Malesia 6
TW - Taiwan 6
BJ - Benin 5
CG - Congo 5
CO - Colombia 5
DZ - Algeria 5
HU - Ungheria 5
JM - Giamaica 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BO - Bolivia 4
CL - Cile 4
DK - Danimarca 4
ET - Etiopia 4
PY - Paraguay 4
YE - Yemen 4
BB - Barbados 3
BH - Bahrain 3
CY - Cipro 3
EE - Estonia 3
HN - Honduras 3
IL - Israele 3
LB - Libano 3
PE - Perù 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
IS - Islanda 2
KN - Saint Kitts e Nevis 2
LC - Santa Lucia 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 21.248
Città #
Woodbridge 1.171
Ann Arbor 1.007
Singapore 887
Ashburn 835
Houston 768
Milan 758
Chandler 700
Hong Kong 681
Santa Clara 566
Hefei 434
Fairfield 426
San Jose 424
Dong Ket 391
Beijing 349
Sofia 338
Dallas 312
Seoul 291
Jacksonville 240
Shanghai 229
Ottawa 206
Wilmington 203
Seattle 174
Izmir 172
Cambridge 171
New York 170
Chicago 165
Los Angeles 158
Boardman 133
Princeton 127
Lawrence 117
Ho Chi Minh City 113
Medford 110
Nanjing 109
Lauterbourg 101
Hanoi 94
Bern 93
Tokyo 93
Abidjan 78
Des Moines 66
Jüchen 63
London 62
Council Bluffs 58
Alessandria 56
Rome 55
Serra 55
Dearborn 53
The Dalles 52
Buffalo 51
Florence 51
Columbus 49
Istanbul 47
Helsinki 42
Munich 42
Boulder 40
Bremen 40
Zurich 40
Nanchang 38
Lagos 37
Vienna 36
Redondo Beach 35
Redwood City 33
São Paulo 33
Frankfurt am Main 32
Lancaster 32
Marseille 32
Ogden 32
Brussels 31
Hyderabad 31
Kocaeli 29
Sacile 29
Kunming 27
North York 26
Paris 26
San Diego 26
Shenyang 26
Düsseldorf 24
Fuzhou 23
Pune 23
Dakar 22
Guangzhou 22
Da Nang 20
Hebei 19
Rio de Janeiro 19
Grafing 18
Baghdad 17
Jiaxing 17
Tianjin 17
Dhaka 16
Orem 16
Haiphong 15
Verona 15
Belo Horizonte 14
Changsha 14
Falls Church 14
Hangzhou 14
Warsaw 13
Chennai 12
Jakarta 12
Johannesburg 12
Nürnberg 12
Totale 15.327
Nome #
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 393
1,2,3-Triazole[4,5-d]pyridazines II. New Derivatives Tested on the Adenosine Receptors 345
1,2,3-Triazolo[1,5-a][1,3]benzodiazepine a new heterocyclic system: Synthesis, benzodiazepine receptor binding and theoretical calculations 336
1,2,3-Triazolo[1,5-a][1,4]- and 1,2,3-Triazolo[1,5-a][1,5]benzodiazepine derivatives: synthesis and benzodiazepine receptor binding. 325
1,2,3 Triazolo[1,2-a]benzotriazoles or 2,3-Benzo-1,3a,6,6a-Tetraazapentalenes 322
An 1,2,3-Triazole Derivative Bioisoster of a Potent in Vitro Prostaglandin Synthesis Inhibitor: Preparation and Biological Activity 319
1,2,3-triazolo [4,5-d] pyridazines-V. Preparation and adenosine receptor binding of new 4-amino derivatives. 312
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 293
1,2,3-TRIAZOLO[4,5-e]-1,2,4-TRIAZOLO[3,4-c]PYRIMIDINES 283
N(6)-SUBSTITUTED 2-PHENYL-9-BENZYL-8-AZAADENINES - AFFINITY FOR ADENOSINE A(1)-RECEPTOR AND A(2)-RECEPTOR - A COMPARISON WITH 2-N-BUTYL ANALOGOUS DERIVATIVES .5. 282
N(6)-SUBSTITUTED 2-N-BUTYL-9-BENZYL-8-AZAADENINES - AFFINITY FOR ADENOSINE A(1)-RECEPTOR AND A(2)-RECEPTOR .4. 276
1,2,3-TRIAZOLE[4,5-D]PYRIDAZINES .3. SYNTHESIS OF NEW 4-AMINO DERIVATIVES AND THEIR AFFINITY TOWARD ADENOSINE RECEPTORS 274
1,2,3-Triazole[4,5-d]pyridazines IV. Preparation and Adenosine Receptor Binding of New 4-and /or 7-Aminoderivatives 267
1,2,3-Triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors 264
1,2,3-Triazolo[4,5-d]-1,2,4-triazolo[4,3-b]pyridazines 264
1,2,3-TRIAZOLO[4,5-D]PYRIDAZINES. PART VI. NEW 1-SUBSTITUTED-4-AMINO DERIVATIVES AND THEIR AFFINITY TOWARDS A1 AND A2 ADENOSINE RECEPTORS 256
1,2,3-Triazolodiazepine I. Preparation and Benzodiazepine Receptor Binding of 1-Benzyl and 1-Phenethyl-1,2,3-Triazolo[4,5-d][1,4]diazepines 255
1,2,3-triazolo[1.5-a]quinazolines: synthesis, benzodiazepine receptor binding and theoretical calculations 252
N(6)-Substituted 2-n-Butyl-9-Benzyl-8-Azaadenines. Affinity for Adenosine A1 and A2 Receptors. IV 251
1,2,3-triazolo[4,5-d]pyridazines - Part VI. New 1-substituted-4-amino derivatives and their affinity towards A(1) and A(2A) adenosine receptors 250
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 248
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 246
N-(9-Benzyl-2-phenyl-9H-8azapurin-6-yl)-amides: A new class of A1 adenosine receptor ligands 243
N(6)CYCLOALKYL-2-PHENYL-3-DEAZA-8-AZAADENINES: A NEW CLASS OF A1ADENOSINE RECEPTOR LIGANDS. A COMPARISON WITH THE CORRESPONDING ADENINES AND 8-AZAADENINES 237
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 231
"One Pot" Synthesis of 2-Substituted 9-(2'-Hydroxy-3'-aminopropyl)-8-azahypoxanthines and 8-Azaadenines [5-Substituted 3-(2'-Hydroxy-3'-aminopropyl)-7-amino and 7-hyroxy- 3H-1,2,3-triazolo[4,5-d]pyrimidines] 227
Synthesis of New 3-Benzyl-5-Phenyl-7-Alkylaminothiazolo[4,5-d]pyrimidine-2(3H)-Thiones.) 222
N(6)-substituted 2-phenyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. A comparison with 2-N-butyl analogous derivatives.5. 221
N-[9-(ortho-Fluorobenzyl)-2-Phenyl-8-Azapurin-6-yl]-Amides as Potent and Selective Ligands for A1 Adenosine Receptors. 221
N(6) or N(9) Substituted 2-Phenyl-8-Azaadenines: Affinity for A1 Adenosine Receptors. VII 219
N(9)-substituted 2-phenyl-N(6)-benzyl-8-azaadenines: A1 adenosine receptor affinity. A comparison with the corresponding N(6)-substituted 2-phenyl-N(9)-benzyl-8-azaadenines 218
Adenosine A1 modulators: a patent update (2008 to present) 215
Novel 8-azapurine derivatives as ligands for A3 adenosine receptors 214
2-Fenyl-9-benzyl-6-arylamido-8-azapurines: new potent ligands of adenosine receptors 213
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 212
8-Azapurine nucleus: a versatile scaffold for different targets 203
A QSAR study of A1adenosine receptor antagonists by a new neural network model 201
NEW 1,2,3-TRIAZOLO[1,5-a]QUINOXALINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS. II 200
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 198
2,9-Disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: Synthesis, biochemical and molecular modelling studies 191
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 186
New amido derivatives as potential BKCa potassium channel activators. XI 186
In vitro Inhibitors of Prostaglandin Synthesis: (p-Thiosubstituted)-Benzyl Nitrogen Heterocycles 183
Studies on 1,2,3-Triazole Derivatives as in vitro Inhibitors of Prostaglandine Synthesis 183
Xanthine Oxidase (XO). 4(5)-Aminosubstituted-5(4)-Carboxyamido-1H-1,2,3-Triazoles: a New Class of Monocyclic Triazole Inhibitors 180
QSAR Studies on Purine and 2,3-Dihydropurine Analogues as Antitubercular Agents 180
Interaction of an improved model of human A1 adenosine receptor with ligands 179
1,2,3-Trizoles[4,5-d]piridazines. Analogues of Prostaglandin Synthesis Inhibitors 178
A 3D model of human A1 adenosine receptor. An evaluation of the binding free energy with ligands 176
QSAR study on purine and 2,3-dihydropurine analogues as antitubercular agents 175
Antimicrobial properties of flavonoids. 175
Studies on Specific Inhibition of Benzodiazepine Receptor Binding by Some C-Benzoyl-1,2,3-triazole Derivatives 175
Xanthine Oxidase Inhibition: Effect of a Linear Carboalkoxy Substituent on C(2) of the Nucleus of 8-Azahypoxanthine 174
3-[(2-Ethoxyphenoxy)methyl]piperidine derivatives. Synthesis and antidepressant activity 174
QSAR study on a novel series of 8-azaadenine analogues proposed as A1 adenosine receptor antagonists 173
Synthesis of N(6)-Substituted 2-Phenyl-8-Azaadenosines. Their Affinity for Adenosine A1 and A2 Receptors: a Comparison with the Corresponding 2-Phenyl-9-Benzyl-8-Azaadenines. 170
New 4-(Benzotriazol-1-yl)-1,2,3-triazole derivatives 170
Introduction of a hydroxy function on N6 8-azaadenine substituents to improve the solubility and the effectiveness of antagonists towards A1 adenosine receptors 170
Evaluation of the Quantitative Contribution of a Phenyl Group on C(2) of 8-Azaadenosine to the Binding with Adenosine Deaminase: a New Synthesis of 8-Azaadenosine. XI. 170
Evaluation of new synthesized “adenine derivatives” molecules as cytokinin-like compounds . 170
XANTHINE-OXIDASE (XO) - RELATIVE CONFIGURATION OF COMPLEXES FORMED BY THE ENZYME, 2-N-ALKYL-HYPOXANTHINE OR 8-N-ALKYL-HYPOXANTHINE AND 2-N-ALKYL-8-AZAHYPOXANTHINES .12. 167
Bioisosterism, enantioselectivity and molecular modeling of new effective N6- and/or N(9)-substituted 2-phenyl adenines and 8-aza analogs: different binding modes to A1 adenosine receptors 167
Modification of the 1,2,3-Triazole Ring Present in an Effective in vitro Inhibitor of Prostaglandin Synthesis 166
Structure-Activity Studies on a 1,2,3-Triazole Derivative, a Potent in vitro Inhibitor of Prostaglandin Synthesys: the Role of the Heterocyclic Ring 165
5-(4'-SUBSTITUTED-2'-NITROANILINO)-1,2,3-TRIAZOLES AS NEW POTENTIAL POTASSIUM CHANNEL ACTIVATORS. I 165
An initial comparison of the content of bitter substances in Cynara Scolymus L. plants obtained from rooted of shoots and micropropagation 165
1-(1,2,3-TRIAZOL-4-YL)-BENZIMIDAZOLONES, A NEW SERIES OF HETEROCYCLIC DERIVATIVES 161
1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII. 159
Alimentazione e qualità della vita 158
Synthesis of New 2-Substituted 9-?-D-Ribofuranosyl-8-Azahypoxanthine 156
TRIAZOLYLBENZIMIDAZOLTHIONES AND DERIVATIVES OF THE NEW 1,2,3-TRIAZOLO[1,5-A][1,3,5]BENZOTRIAZEPINE HETEROCYCLE 154
ERYTHRO AND THREO 2-HYDROXYNONYL SUBSTITUTED 2-PHENYLADENINES AND 2-PHENYL-8-AZAADENINES: LIGANDS FOR A1 ADENOSINE RECEPTORS AND ADENOSINE DEAMINASE 153
Synthesis and functional evaluation of Adenosine A2A receptor ligand 152
Synthesis of New 1,2,3-triazolo[1,2-a]benzotriazole derivatives or substituted 2,3-benzo-1,3a,6,6a-tetraazapentalenes. II” 151
New Chiral Inhibitors of Induced Platelet Aggregation: the Enantiomeric Specificity of (R)- and (S)-Methyl and Ethyl Esters of 1-{p-[(1-Hydroxycarbonyl)-ethyloxy]-benzyl}-1H-1,2,3-triazole as a Tool for Determining their Biological Target. 150
Synthesis of new 2-phenyladenines and 2-phenylpteridines and biological evaluation as adenosine receptor ligands 150
An 1,2,3,Triazole Derivatives Bioisoster of a Potent in vitro Prostaglandin Synthesis Inhibitor: Preparation and Biological Activity 149
Xanthine Oxidase (XO): Relative Configuration of Complexes Formed by the Enzyme, 2- or 8-n-Alkyl-hypoxanthines and 2-n-Alkyl-8-azahypoxanthines. XII 149
A Method for the Synthesis of Racemic and Optically Active 2-Substituted 9-(2',3'-Dihidroxypropyl)-8-Azahypoxanthines and 8-Azaadenines 147
2-ALKYLOXYALKYLTHIOHYPOXANTHINES AS NEW POTENT INHIBITORS OF XANTHINE OXIDASE 145
THERAPEUTIC POTENTIAL OF A1 ADENOSINE RECEPTOR LIGANDS: A SURVEY OF RECENT PATENT LITERATURE 145
SOME STRUCTURAL CHANGES ON TRIAZOLYL-BENZOTRIAZOLES AND TRIAZOLYL-BENZIMIDAZOLONES AS POTENTIAL POTASSIUM CHANNEL ACTIVATORS. III 143
Synthesis and ADA Inhibitory Activity of New 2-Aryl-8-Azaadenosines 141
Xanthine Oxidase (XO). Synthesis of 4(5)-Carbxyamido-5(4)-aminoalkanoyl)amino-1,2,3-triazoles and Their Cyclization to 8-Azahypoxanthines. Evaluation for Inhibition of XO. 139
Interactions of an improved model of the the Human A1 Adenosine Receptor with Ligands 139
Steroeselectivity as an evidence for a double insertion of Antagonists within A1 Adenosine Receptors 138
NEW 1,2,3-TRIAZOLO[4,5-E]1,2,3-TRIAZOLO[4,3-C]PYRIMIDINE DERIVATIVES.II 138
Synthesis and Biological Evaluation of New Imidazole, Pyrimidine and Purine Derivatives and Analogs as Inhibitors of Xanthine Oxidase 136
NEW 5-SUBSTITUTED-1-(2-HYDROXYBENZOYL)-BENZOTRIAZOLES, POTASSIUM CHANNELS ACTIVATORS. IV 136
THE NEW DEGREE IN TECHICHE ERBORISTICHE (HERBAL TECHNOLOGY) 134
SUBSTITUTED 1,2,3-TRIAZOLO[1,5-A]QUINAZOLINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS 133
A 3D Model of the Human A1 Adenosine Receptor. An Evaluation of the Binding Free-Energy with Ligands 132
Synthesis of analogs of (±)-EHNA as potent inhibitors of ADA 131
Structural modifications of benzanilide derivatives, effective potassium channel openers. X 131
Chemistry of the Dihydrothiazine Ring Moiety of Cephalosporins. A Route to 3-Formoxymethyl-3-Cephem Derivatives 128
Heterocyclic analogs of benzanilide derivatives as potassium channel activators. IX 128
NEW N6-OR N(9)-HYDROXYALKYL SUBSTITUTED 8-AZAADENINES OR ADENINES AS AFFECTIVE A1 ADENOSINE RECEPTOR LIGANDS 128
1,5-Diarylsubstituted 1,2,3-triazoles as potential potassium channels activators. VI. 123
New amino derivatives of 1,2,3-triazolo[4,5-D]pyrimidines and their affinity towards A1 and A2A adenosune receptors 123
Triazolyl-benzimidazolones and triazolyl-benzotriazoles: new potential potassium channel activators. II 120
Totale 19.521
Categoria #
all - tutte 54.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.699


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.459 16 119 20 110 259 198 15 100 87 14 91 430
2022/20231.873 254 240 118 208 217 239 30 138 304 7 101 17
2023/20242.134 319 238 365 218 313 224 29 56 25 58 44 245
2024/20254.036 46 146 41 212 429 407 286 229 355 455 528 902
2025/20264.498 481 674 518 258 407 395 845 178 230 322 122 68
2026/202728 28 0 0 0 0 0 0 0 0 0 0 0
Totale 21.341